GRI Bio Inc. Cash Flow-to-Debt Ratio
GRI Bio Inc. cash flow-to-debt ratio. GRI Bio Inc. (GRI) has a Cash Flow-to-Debt Ratio of -1.31x as of June 2026, meaning its operating cash flow of $-1.45 Million could theoretically repay -1% of its total liabilities ($1.10 Million) in one year. Check GRI operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GRI Bio Inc. (2018–2025)
Cash flow-to-debt ratio of GRI Bio Inc. from 2018 to 2025. Historical debt coverage capacity for GRI Bio Inc. across 8 annual periods. Check GRI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
GRI Bio Inc. Cash Flow-to-Debt Ratio by Year (2018–2025)
GRI Bio Inc. cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for GRI Bio Inc.. For the full cash flow conversion analysis, see GRI cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.83x | $-10.19 Million | $2.66 Million | ▲ +24.0% |
| 2024 | -5.04x | $-8.61 Million | $1.71 Million | ▼ -51.3% |
| 2023 | -3.33x | $-8.99 Million | $2.70 Million | ▼ -516.9% |
| 2022 | -0.54x | $-1.08 Million | $2.01 Million | ▲ +67.9% |
| 2021 | -1.68x | $-8.31 Million | $4.94 Million | ▼ -9.3% |
| 2020 | -1.54x | $-3.71 Million | $2.41 Million | ▲ +43.4% |
| 2019 | -2.72x | $-2.88 Million | $1.06 Million | ▲ +44.3% |
| 2018 | -4.88x | $-2.37 Million | $486.29K | — |